CYP19A1 and polycystic ovary syndrome: Current animal models (prenatal/postnatal androgen treatment, anti-Mullerian hormone administration, and aromatase inhibition) are hyperandrogenic models which primarily recapitulate the hormonal environment of PCOS but cannot fully capture the genetic and epigenetic factors underlying human PCOS pathogenesis.